257 related articles for article (PubMed ID: 2155117)
1. In vitro transformation by Epstein-Barr virus induces a switch in growth factor and anti-IgM responsiveness in a human leukemic B cell clone.
Janssen O; Gillis S; Kabelitz D
Eur J Immunol; 1990 Jan; 20(1):7-14. PubMed ID: 2155117
[TBL] [Abstract][Full Text] [Related]
2. Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines.
Gibbons DL; Rowe M; Cope AP; Feldmann M; Brennan FM
Eur J Immunol; 1994 Aug; 24(8):1879-85. PubMed ID: 8056047
[TBL] [Abstract][Full Text] [Related]
3. Immortalization of EBV-infected B cells is not influenced by exogenous signals acting on B cell proliferation. Effects of mutant EL-4 thymoma cells and transforming growth factor-beta.
Straub C; Zubler RH
J Immunol; 1989 Jan; 142(1):87-93. PubMed ID: 2535862
[TBL] [Abstract][Full Text] [Related]
4. Loss of transforming growth factor beta 1 receptors and its effects on the growth of EBV-transformed human B cells.
Kumar A; Rogers T; Maizel A; Sharma S
J Immunol; 1991 Aug; 147(3):998-1006. PubMed ID: 1713611
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr-virus-transformed lymphoblastoid cell lines derived from patients with X-linked agammaglobulinaemia and Wiskott-Aldrich syndrome: responses to B cell growth and differentiation factors.
Lau YL; Shields JG; Levinsky RJ; Callard RE
Clin Exp Immunol; 1989 Feb; 75(2):190-5. PubMed ID: 2539277
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity in both cytokine production and responsiveness of a panel of monoclonal human Epstein-Barr virus-transformed B-cell lines.
Jochems GJ; Klein MR; Jordens R; Pascual-Salcedo D; van Boxtel-Oosterhof F; van Lier RA; Zeijlemaker WP
Hum Antibodies Hybridomas; 1991 Apr; 2(2):57-64. PubMed ID: 1651786
[TBL] [Abstract][Full Text] [Related]
7. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2.
Tseng CT; Springgate CF; Piela TH; Choi YS
J Immunol; 1987 Apr; 138(8):2554-60. PubMed ID: 3031160
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus mediates a switch in responsiveness to transforming growth factor, type beta, in cells of the B cell lineage.
Blomhoff HK; Smeland E; Mustafa AS; Godal T; Ohlsson R
Eur J Immunol; 1987 Feb; 17(2):299-301. PubMed ID: 3030769
[TBL] [Abstract][Full Text] [Related]
9. Regulation of germ-line epsilon transcription and induction of epsilon switching in cloned EBV-transformed and malignant human B cell lines by cytokines and CD4+ T cells.
Gauchat JF; Gascan H; de Waal Malefyt R; de Vries JE
J Immunol; 1992 Apr; 148(7):2291-9. PubMed ID: 1347554
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-immortalized B cells produce IL-6 as an autocrine growth factor.
Yokoi T; Miyawaki T; Yachie A; Kato K; Kasahara Y; Taniguchi N
Immunology; 1990 May; 70(1):100-5. PubMed ID: 2162322
[TBL] [Abstract][Full Text] [Related]
11. Recombinant IL 2 but not recombinant interferon-gamma stimulates both proliferation and IgM secretion in a Ly-1+ clone of neoplastic murine B cells (BCL1).
Brooks KH; Vitetta ES
J Immunol; 1986 Nov; 137(10):3205-10. PubMed ID: 2945863
[TBL] [Abstract][Full Text] [Related]
12. Production and regulation of interleukin 6 in human B lymphoid cells.
Hutchins D; Cohen BB; Steel CM
Eur J Immunol; 1990 May; 20(5):961-8. PubMed ID: 2113479
[TBL] [Abstract][Full Text] [Related]
13. Human recombinant interleukin 4 induces normal B cells to produce soluble CD23/IgE-binding factor analogous to that spontaneously released by lymphoblastoid B cell lines.
Bonnefoy JY; Defrance T; Peronne C; Menetrier C; Rousset F; Pène J; De Vries JE; Banchereau J
Eur J Immunol; 1988 Jan; 18(1):117-22. PubMed ID: 2831064
[TBL] [Abstract][Full Text] [Related]
14. T4 cell activation by immobilized phytohemagglutinin: differential capacity to induce IL-2 responsiveness and IL-2 production.
Vine JB; Geppert TD; Lipsky PE
J Immunol; 1988 Oct; 141(8):2593-600. PubMed ID: 2844904
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of responsiveness of chronic lymphocytic leukemic B cells to B cell growth factor or interleukin 2.
Hivroz C; Grillot-Courvalin C; Brouet JC; Seligmann M
Eur J Immunol; 1986 Aug; 16(8):1001-4. PubMed ID: 3488907
[TBL] [Abstract][Full Text] [Related]
16. Phenotype, frequency, and EBV responsiveness of human marrow B and pre-B cells.
Hibi T; Chan MA; Petsche D; Dosch HM
J Immunol; 1986 May; 136(9):3211-8. PubMed ID: 3007613
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of EBV-transformable human B lymphocyte populations.
Chan MA; Stein LD; Dosch HM; Sigal NH
J Immunol; 1986 Jan; 136(1):106-12. PubMed ID: 2999241
[TBL] [Abstract][Full Text] [Related]
18. Polyclonal B cell activation induced by herpesvirus saimiri-transformed human CD4+ T cell clones. Role for membrane TNF-alpha/TNF-alpha receptors and CD2/CD58 interactions.
Del Prete G; De Carli M; D'Elios MM; Fleckenstein IM; Fickenscher H; Fleckenstein B; Almerigogna F; Romagnani S
J Immunol; 1994 Dec; 153(11):4872-9. PubMed ID: 7525717
[TBL] [Abstract][Full Text] [Related]
19. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
[TBL] [Abstract][Full Text] [Related]
20. Properties of a specific interleukin 1 (IL 1) receptor on human Epstein Barr virus-transformed B lymphocytes: identity of the receptor for IL 1-alpha and IL 1-beta.
Matsushima K; Akahoshi T; Yamada M; Furutani Y; Oppenheim JJ
J Immunol; 1986 Jun; 136(12):4496-502. PubMed ID: 3011895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
